בלסטווין טבע

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

VINBLASTINE SULFATE

Mevcut itibaren:

ABIC MARKETING LTD, ISRAEL

ATC kodu:

L01CA01

Farmasötik formu:

תמיסה להזרקה

Kompozisyon:

VINBLASTINE SULFATE 1 MG / 1 ML

Uygulama yolu:

תוך-ורידי

Reçete türü:

אין צורך במרשם

Tarafından üretildi:

PHARMACHEMIE B.V., (TEVA GROUP) ,THE NETHERLANDS

Terapötik grubu:

VINBLASTINE

Terapötik alanı:

VINBLASTINE

Terapötik endikasyonlar:

Vinblastine has proved effective in the treatment of the following neoplasms, either alone or in conjunction with other oncolytic drugs:Frequently Responsive Malignancies :• Generalized Hodgkin's disease (Stages III and IV, Ann Arbor modification of Rye staging system)• Non-Hodgkin's lymphoma: - Reticulum-cell sarcoma - Lymphosarcoma• Mycosis fungoides.• Neuroblastoma.• Histiocytosis X.Less Frequently Responsive Malignancies :• Choriocarcinoma resistant to other chemotherapeutic agents.• Embryonal carcinoma of the testis.• Carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy.

Yetkilendirme tarihi:

2016-08-31